Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.

被引：0

作者：

Ajani, Jaffer A.

Leung, Lisa

Kanters, Steve

Singh, Prianka

Kurt, Murat

Kim, Inkyu

Pourrahmat, Mir-Masoud

Friedman, Howard S.

Navaratnam, Prakash

Reardon, Gregory

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] Evidinno Outcomes Res Inc, Vancouver, BC, Canada

[3] Bristol Myers Squibb, Lawrenceville, NJ USA

[4] DataMed Solut LLC, New York, NY USA

[5] Keck Grad Inst, Claremont, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

321

引用

页码：321 / 321

页数：1